RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Regulatory Agency Hub

MHRA Updates

The latest guidances, approvals, and safety alerts from MHRA, curated by automated regulatory intelligence.

OTHER
Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets, EL(26)A/48
MHRA (UK) • Published: Nov 12, 2026

Rectifies a carton labeling typographical error where hydrochlorothiazide strength was printed as “12.

cardiology
labeling
+2
View update →
OTHER
Field Safety Notices from 02 to 06 November2026.
MHRA (UK) • Published: Nov 10, 2026

Publishes an MHRA list of Field Safety Notices issued between 02 and 06 October 2026, indicating active post-market safety communications affecting regulated…

safety
quality
+3
View update →
OTHER
Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/5mL, EL(26)A/46
MHRA (UK) • Published: Nov 5, 2026

Class 4 defect notification informs that Sandoz has reported errors in the Co-amoxiclav SmPC dosing table for 250/62.5 mg/5 mL oral suspension.

infectious_disease
pediatrics
+3
View update →
OTHER
Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml , EL(26)A/47
MHRA (UK) • Published: Nov 5, 2026

Initiates a Class 3 medicines recall for specific batches of Tropicamide 1% eye drops in single-dose containers due to incorrect expiry dates on the labels.

ophthalmology
quality
+3
View update →
OTHER
Field Safety Notices: 26 to 30 October 2026
MHRA (UK) • Published: Nov 4, 2026

Lists MHRA Field Safety Notices issued between 26 and 30 October 2026, signalling active post-market safety communications across affected products.

safety
labeling
+2
View update →
OTHER
MHRA Safety Roundup: October 2026
MHRA (UK) • Published: Oct 30, 2026

Provides a roundup of the latest MHRA safety advice for medicines and medical device users, which may signal emerging safety concerns and updated risk…

safety
labeling
+1
View update →
OTHER
Class 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45
MHRA (UK) • Published: Oct 29, 2026

Initiates a Class 2 medicines recall by Accord-UK Ltd for a single batch of lercanidipine hydrochloride 10 mg film-coated tablets due to a packaging mix-up…

cardiology
safety
+2
View update →
OTHER
Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44
MHRA (UK) • Published: Oct 29, 2026

Initiates a precautionary Class 2 medicines recall for specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringes by Advanz Pharma…

safety
quality
+1
View update →
OTHER
Field Safety Notices: 19 to 23 October 2026
MHRA (UK) • Published: Oct 28, 2026

Field Safety Notices (FSNs) issued between 19 and 23 October 2026 are listed, which may require manufacturers and supply-chain partners to review…

safety
manufacturing
+3
View update →
OTHER
Class 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/43
MHRA (UK) • Published: Oct 26, 2026

Initiates a Class 2 medicines recall related to Xeal Pharma clopidogrel oral suspension and oral solution products because testing indicates the finished…

cardiology
pediatrics
+4
View update →
OTHER
Field Safety Notices: 5 to 9 October 2026
MHRA (UK) • Published: Oct 19, 2026

Publishes an MHRA register entry listing Field Safety Notices issued during 5 to 9 October 2026.

safety
quality
+1
View update →
OTHER
Field Safety Notices: 12 to 16 October 2026
MHRA (UK) • Published: Oct 19, 2026

Publishes a list of MHRA Field Safety Notices issued between 12 and 16 October 2026, highlighting active post-market safety communications that may require…

safety
manufacturing
+2
View update →
OTHER
Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/013
MHRA (UK) • Published: Oct 16, 2026

Identifies specified lots of Nova Biomedical StatStrip ketone test strips with quality-control (QC) failures, prompting a recall due to potential unreliability…

manufacturing
quality
+3
View update →
OTHER
Field Safety Notices: 27 to 31 January 2025
MHRA (UK) • Published: Oct 16, 2026

Publication listing MHRA Field Safety Notices issued between 27 and 31 January 2025.

safety
quality
+3
View update →
OTHER
Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/014
MHRA (UK) • Published: Oct 13, 2026

Recommends considering delayed administration of concurrent echinocandins (e.g., caspofungin) during CRRT using new polyacrylonitrile (PAN)-based filter…

infectious_disease
clinical
+3
View update →
OTHER
Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42
MHRA (UK) • Published: Oct 12, 2026

Initiates a Class 2 recall of Pedmarqsi 80 mg/mL solution for infusion for specified batches due to a risk of particulate matter detected during routine…

pediatrics
manufacturing
+3
View update →
OTHER
Field Safety Notices for October 2026
MHRA (UK) • Published: Oct 9, 2026

Field Safety Notices for October 2026 indicates a planned set of MHRA safety communications that may trigger updated risk controls, handling instructions, or…

safety
quality
+3
View update →
OTHER
Field Safety Notices: 8 -12 June 2026
MHRA (UK) • Published: Oct 9, 2026

Field Safety Notices (FSNs) for 8–12 June 2026 are listed, indicating an ongoing series of safety communications that may require manufacturers, distributors…

safety
labeling
+1
View update →
OTHER
Field Safety Notices: 28 September 2026 to 2 October 2026
MHRA (UK) • Published: Oct 9, 2026

Field Safety Notices are being issued/updated over 21–25 September 2026, with a list published for the period 28 September–2 October 2026.

safety
quality
+3
View update →
OTHER
Class 3 Medicines Recall: Norgine Limited, MOVICOL Plain 13.7g powder for oral solution, EL(26)A/41
MHRA (UK) • Published: Oct 5, 2026

Initiates a Class 3 medicines recall by Norgine Limited for specific batches of MOVICOL Plain 13.7g powder for oral solution as a precautionary response to…

gastroenterology
safety
+1
View update →

Get MHRA alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.